Association of combined complement factor H Y402H and ARMS2/LOC387715 A69S polymorphisms with age-related macular degeneration: an updated meta-analysis
Complement factor H (CFH) Y402 H (rs1061170) and age-related maculopathy susceptibility2 (ARMS2)/LOC387715 A69 S (rs10490924) polymorphisms shown to have significant association with AMD. In this meta-analysis, we updated and pooled the results of available association studies between combined ARMS2...
Saved in:
Published in | Ophthalmic genetics Vol. 41; no. 4; pp. 301 - 307 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
England
Taylor & Francis
03.07.2020
|
Subjects | |
Online Access | Get full text |
ISSN | 1381-6810 1744-5094 1744-5094 |
DOI | 10.1080/13816810.2020.1765396 |
Cover
Loading…
Abstract | Complement factor H (CFH) Y402 H (rs1061170) and age-related maculopathy susceptibility2 (ARMS2)/LOC387715 A69 S (rs10490924) polymorphisms shown to have significant association with AMD. In this meta-analysis, we updated and pooled the results of available association studies between combined ARMS2/LOC387715A69 S-CFHY402 H genotypes and AMD to estimate the synergistic effects.
Heterogeneity of studies was evaluated using Cochran Q-test and I-square index. To modify the heterogeneity in the variables we used random effects model. Meta-analysis was performed using STATA. To estimate the additive or supra-additive effects we calculated RERI (relative excess risk due to interaction), AP (attributable proportion due to interaction), S (synergy index) and V (multiplicative index).
We included 12 studies with 4668 AMD patients and 4936 control subjects. Considering the GGTT genotypes as reference line, the pooled AMD odds ratios for stratified combined genotypes was 2.13 (95% CI 1.64-2.78) for GGnonTT, 2.17 (95% CI 1.63-2.89) for nonGGTT and 7.23 (95% CI 4.95-10.55) for nonGGnonTT. Pooled synergy analysis revealed RERI = 3.90 (95% CI 0.58-10.03), AP = .53 (95% CI 0.09-0.69), S = 2.57 (95% CI 1.27-5.22) and V = 1.47 (95% CI 1.21-1.80).
This updated analysis showed a strong synergistic and positive multiplicative effect of these two genes indicating that there is common pathway of ARMS2/LOC387715 A69 S and CFH Y402 H in AMD pathogenesis which may be complement system pathway. |
---|---|
AbstractList | Complement factor H (CFH) Y402 H (rs1061170) and age-related maculopathy susceptibility2 (ARMS2)/LOC387715 A69 S (rs10490924) polymorphisms shown to have significant association with AMD. In this meta-analysis, we updated and pooled the results of available association studies between combined ARMS2/LOC387715A69 S-CFHY402 H genotypes and AMD to estimate the synergistic effects.
Heterogeneity of studies was evaluated using Cochran Q-test and I-square index. To modify the heterogeneity in the variables we used random effects model. Meta-analysis was performed using STATA. To estimate the additive or supra-additive effects we calculated RERI (relative excess risk due to interaction), AP (attributable proportion due to interaction), S (synergy index) and V (multiplicative index).
We included 12 studies with 4668 AMD patients and 4936 control subjects. Considering the GGTT genotypes as reference line, the pooled AMD odds ratios for stratified combined genotypes was 2.13 (95% CI 1.64-2.78) for GGnonTT, 2.17 (95% CI 1.63-2.89) for nonGGTT and 7.23 (95% CI 4.95-10.55) for nonGGnonTT. Pooled synergy analysis revealed RERI = 3.90 (95% CI 0.58-10.03), AP = .53 (95% CI 0.09-0.69), S = 2.57 (95% CI 1.27-5.22) and V = 1.47 (95% CI 1.21-1.80).
This updated analysis showed a strong synergistic and positive multiplicative effect of these two genes indicating that there is common pathway of ARMS2/LOC387715 A69 S and CFH Y402 H in AMD pathogenesis which may be complement system pathway. Complement factor H (CFH) Y402 H (rs1061170) and age-related maculopathy susceptibility2 (ARMS2)/LOC387715 A69 S (rs10490924) polymorphisms shown to have significant association with AMD. In this meta-analysis, we updated and pooled the results of available association studies between combined ARMS2/LOC387715A69 S-CFHY402 H genotypes and AMD to estimate the synergistic effects.BACKGROUNDComplement factor H (CFH) Y402 H (rs1061170) and age-related maculopathy susceptibility2 (ARMS2)/LOC387715 A69 S (rs10490924) polymorphisms shown to have significant association with AMD. In this meta-analysis, we updated and pooled the results of available association studies between combined ARMS2/LOC387715A69 S-CFHY402 H genotypes and AMD to estimate the synergistic effects.Heterogeneity of studies was evaluated using Cochran Q-test and I-square index. To modify the heterogeneity in the variables we used random effects model. Meta-analysis was performed using STATA. To estimate the additive or supra-additive effects we calculated RERI (relative excess risk due to interaction), AP (attributable proportion due to interaction), S (synergy index) and V (multiplicative index).METHODSHeterogeneity of studies was evaluated using Cochran Q-test and I-square index. To modify the heterogeneity in the variables we used random effects model. Meta-analysis was performed using STATA. To estimate the additive or supra-additive effects we calculated RERI (relative excess risk due to interaction), AP (attributable proportion due to interaction), S (synergy index) and V (multiplicative index).We included 12 studies with 4668 AMD patients and 4936 control subjects. Considering the GGTT genotypes as reference line, the pooled AMD odds ratios for stratified combined genotypes was 2.13 (95% CI 1.64-2.78) for GGnonTT, 2.17 (95% CI 1.63-2.89) for nonGGTT and 7.23 (95% CI 4.95-10.55) for nonGGnonTT. Pooled synergy analysis revealed RERI = 3.90 (95% CI 0.58-10.03), AP = .53 (95% CI 0.09-0.69), S = 2.57 (95% CI 1.27-5.22) and V = 1.47 (95% CI 1.21-1.80).RESULTSWe included 12 studies with 4668 AMD patients and 4936 control subjects. Considering the GGTT genotypes as reference line, the pooled AMD odds ratios for stratified combined genotypes was 2.13 (95% CI 1.64-2.78) for GGnonTT, 2.17 (95% CI 1.63-2.89) for nonGGTT and 7.23 (95% CI 4.95-10.55) for nonGGnonTT. Pooled synergy analysis revealed RERI = 3.90 (95% CI 0.58-10.03), AP = .53 (95% CI 0.09-0.69), S = 2.57 (95% CI 1.27-5.22) and V = 1.47 (95% CI 1.21-1.80).This updated analysis showed a strong synergistic and positive multiplicative effect of these two genes indicating that there is common pathway of ARMS2/LOC387715 A69 S and CFH Y402 H in AMD pathogenesis which may be complement system pathway.CONCLUSIONThis updated analysis showed a strong synergistic and positive multiplicative effect of these two genes indicating that there is common pathway of ARMS2/LOC387715 A69 S and CFH Y402 H in AMD pathogenesis which may be complement system pathway. : Complement factor H (CFH) Y402 H (rs1061170) and age-related maculopathy susceptibility2 (ARMS2)/LOC387715 A69 S (rs10490924) polymorphisms shown to have significant association with AMD. In this meta-analysis, we updated and pooled the results of available association studies between combined ARMS2/LOC387715A69 S-CFHY402 H genotypes and AMD to estimate the synergistic effects. : Heterogeneity of studies was evaluated using Cochran Q-test and I-square index. To modify the heterogeneity in the variables we used random effects model. Meta-analysis was performed using STATA. To estimate the additive or supra-additive effects we calculated RERI (relative excess risk due to interaction), AP (attributable proportion due to interaction), S (synergy index) and V (multiplicative index). : We included 12 studies with 4668 AMD patients and 4936 control subjects. Considering the GGTT genotypes as reference line, the pooled AMD odds ratios for stratified combined genotypes was 2.13 (95% CI 1.64-2.78) for GGnonTT, 2.17 (95% CI 1.63-2.89) for nonGGTT and 7.23 (95% CI 4.95-10.55) for nonGGnonTT. Pooled synergy analysis revealed RERI = 3.90 (95% CI 0.58-10.03), AP = .53 (95% CI 0.09-0.69), S = 2.57 (95% CI 1.27-5.22) and V = 1.47 (95% CI 1.21-1.80). : This updated analysis showed a strong synergistic and positive multiplicative effect of these two genes indicating that there is common pathway of ARMS2/LOC387715 A69 S and CFH Y402 H in AMD pathogenesis which may be complement system pathway. |
Author | Yaseri, Mehdi Jabbarpoor Bonyadi, Mohammad Hossein Soheilian, Masoud |
Author_xml | – sequence: 1 givenname: Mohammad Hossein surname: Jabbarpoor Bonyadi fullname: Jabbarpoor Bonyadi, Mohammad Hossein email: mhbonyadi@yahoo.com organization: Shahid Beheshti University of Medical Sciences – sequence: 2 givenname: Mehdi orcidid: 0000-0002-4066-873X surname: Yaseri fullname: Yaseri, Mehdi organization: Tehran University of Medical Sciences – sequence: 3 givenname: Masoud surname: Soheilian fullname: Soheilian, Masoud organization: Shahid Beheshti University of Medical Sciences |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32406777$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkc1u1DAUhSNURH_gEUBesgm148ROYMNoBAzSoEoUFqysG_-0Ro4dbEfVvAmPi6czs2EBK19b3zlXPueyOvPB66p6SfAbgnt8TWhPWF9uDW7KE2cdHdiT6oLwtq07PLRnZS5MvYfOq8uUfmLcNIR0z6pz2rSYcc4vqt-rlIK0kG3wKBgkwzRar9V-mJ2etM_IgMwhog360eJmg8ArtPr65ba53t6sac856dCKDbdoDm43hTjf2zQl9GDzPYI7XUftIBfHCeTiICKl77TX8XHl2-KGllkdAJ2hBg9ul2x6Xj014JJ-cTyvqu8fP3xbb-rtzafP69W2lpSxXNMGaIt7OhiuB23Gnipj2kFTrTvWMa5AAmes7doeVG9GKkeuejx2Sikzkp5eVa8PvnMMvxadsphskto58DosSZSkKC55EVbQV0d0GSetxBztBHEnTmkW4N0BkDGkFLUR0ubHf-YI1gmCxb47cepO7LsTx-6KuvtLfVrwP937g856E-IEDyE6JTLsXIgmgpc2Cfpviz9Uwa_v |
CitedBy_id | crossref_primary_10_3389_fgene_2023_1077297 crossref_primary_10_2147_OPTH_S298310 crossref_primary_10_3390_jpm11121329 crossref_primary_10_1093_aje_kwae325 |
Cites_doi | 10.1111/ahg.12311 10.1111/aos.13849 10.1074/jbc.M605083200 10.3109/02713683.2016.1158274 10.1001/archophthalmol.2011.10 10.1038/ng.170 10.1167/iovs.09-3850 10.1159/000350549 10.1038/s41433-018-0170-8 10.1093/hmg/ddi353 10.1136/bjo.2010.194712 10.1093/hmg/ddl220 10.1086/504300 10.18632/oncotarget.23241 10.1111/aos.12799 10.1093/hmg/ddl396 10.1167/iovs.08-3240 10.1001/archopht.125.1.55 10.1111/j.1755-3768.2009.01687.x 10.1167/iovs.09-3928 10.1093/hmg/ddm212 10.1007/s00251-004-0660-7 10.1007/s00439-010-0805-8 10.1371/journal.pone.0003833 10.1016/j.ophtha.2010.06.040 10.3980/j..2222-3959.2012.02.02 10.1001/archophthalmol.2009.237 10.1080/13816810.2017.1393829 10.1080/13816810.2016.1237664 10.1007/s00417-013-2442-0 10.1186/s12974-016-0776-3 |
ContentType | Journal Article |
Copyright | 2020 Taylor & Francis Group, LLC 2020 |
Copyright_xml | – notice: 2020 Taylor & Francis Group, LLC 2020 |
DBID | AAYXX CITATION NPM 7X8 |
DOI | 10.1080/13816810.2020.1765396 |
DatabaseName | CrossRef PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1744-5094 |
EndPage | 307 |
ExternalDocumentID | 32406777 10_1080_13816810_2020_1765396 1765396 |
Genre | Review Journal Article |
GroupedDBID | --- 00X 03L 0BK 0R~ 123 29N 36B 4.4 AALUX AAMIU AAPUL AAQRR ABBKH ABDBF ABEIZ ABJNI ABLIJ ABLKL ABUPF ABXYU ACENM ACGEJ ACGFS ACIEZ ACUHS ADCVX ADRBQ ADXPE AECIN AENEX AEOZL AFKVX AGDLA AGFJD AGRBW AGYJP AIJEM AIRBT AJWEG AKBVH ALMA_UNASSIGNED_HOLDINGS ALQZU ALYBC AMDAE BABNJ BLEHA BOHLJ CCCUG CS3 DKSSO DU5 EAP EBC EBD EBS EBX EMB EMK EMOBN EPL ESX F5P H13 HZ~ KRBQP KSSTO KWAYT KYCEM LJTGL M4Z O9- P2P RNANH RVRKI SV3 TBQAZ TDBHL TERGH TFDNU TFL TFW TUROJ TUS UEQFS V1S ~1N AAGDL AAYXX ABWVI ADYSH AFRVT AMPGV CITATION NPM 7X8 TASJS |
ID | FETCH-LOGICAL-c366t-32a340839f7e9efb83dff49e3ee56567daca7664548ad8fb3cb7d80b5dddfb183 |
ISSN | 1381-6810 1744-5094 |
IngestDate | Fri Sep 05 11:08:09 EDT 2025 Wed Feb 19 02:29:59 EST 2025 Thu Apr 24 22:56:34 EDT 2025 Tue Jul 01 04:21:40 EDT 2025 Wed Dec 25 09:08:12 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | ARMS2/LOC387715 A69S age-related macular degeneration (AMD) CFH Y402H Meta-analysis synergistic effect |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c366t-32a340839f7e9efb83dff49e3ee56567daca7664548ad8fb3cb7d80b5dddfb183 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
ORCID | 0000-0002-4066-873X |
PMID | 32406777 |
PQID | 2403032416 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_2403032416 pubmed_primary_32406777 crossref_citationtrail_10_1080_13816810_2020_1765396 informaworld_taylorfrancis_310_1080_13816810_2020_1765396 crossref_primary_10_1080_13816810_2020_1765396 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2020-07-03 |
PublicationDateYYYYMMDD | 2020-07-03 |
PublicationDate_xml | – month: 07 year: 2020 text: 2020-07-03 day: 03 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Ophthalmic genetics |
PublicationTitleAlternate | Ophthalmic Genet |
PublicationYear | 2020 |
Publisher | Taylor & Francis |
Publisher_xml | – name: Taylor & Francis |
References | e_1_3_3_30_1 Tong Y (e_1_3_3_6_1) 2010; 16 e_1_3_3_18_1 e_1_3_3_17_1 e_1_3_3_19_1 e_1_3_3_14_1 e_1_3_3_13_1 e_1_3_3_35_1 e_1_3_3_15_1 e_1_3_3_36_1 e_1_3_3_10_1 e_1_3_3_33_1 e_1_3_3_34_1 e_1_3_3_12_1 e_1_3_3_11_1 e_1_3_3_32_1 e_1_3_3_7_1 e_1_3_3_9_1 e_1_3_3_8_1 e_1_3_3_28_1 Xu Y (e_1_3_3_31_1) 2008; 28 Yasuma TR (e_1_3_3_16_1) 2010; 16 e_1_3_3_25_1 e_1_3_3_24_1 e_1_3_3_27_1 e_1_3_3_26_1 e_1_3_3_3_1 e_1_3_3_21_1 Nazari Khanamiri H (e_1_3_3_29_1) 2014; 9 e_1_3_3_2_1 e_1_3_3_20_1 e_1_3_3_5_1 e_1_3_3_23_1 e_1_3_3_4_1 e_1_3_3_22_1 |
References_xml | – ident: e_1_3_3_24_1 doi: 10.1111/ahg.12311 – ident: e_1_3_3_4_1 doi: 10.1111/aos.13849 – ident: e_1_3_3_8_1 doi: 10.1074/jbc.M605083200 – ident: e_1_3_3_21_1 doi: 10.3109/02713683.2016.1158274 – ident: e_1_3_3_20_1 doi: 10.1001/archophthalmol.2011.10 – ident: e_1_3_3_12_1 doi: 10.1038/ng.170 – ident: e_1_3_3_13_1 doi: 10.1167/iovs.09-3850 – ident: e_1_3_3_27_1 doi: 10.1159/000350549 – volume: 16 start-page: 2923 year: 2010 ident: e_1_3_3_16_1 article-title: Elevated C-reactive protein levels and ARMS2/HTRA1 gene variants in subjects without age-related macular degeneration publication-title: Mol Vis – ident: e_1_3_3_7_1 doi: 10.1038/s41433-018-0170-8 – ident: e_1_3_3_9_1 doi: 10.1093/hmg/ddi353 – ident: e_1_3_3_2_1 doi: 10.1136/bjo.2010.194712 – ident: e_1_3_3_5_1 doi: 10.1093/hmg/ddl220 – ident: e_1_3_3_34_1 doi: 10.1086/504300 – ident: e_1_3_3_25_1 doi: 10.18632/oncotarget.23241 – ident: e_1_3_3_23_1 doi: 10.1111/aos.12799 – volume: 16 start-page: 1958 year: 2010 ident: e_1_3_3_6_1 article-title: LOC387715/HTRA1 gene polymorphisms and susceptibility to age-related macular degeneration: A HuGE review and meta-analysis publication-title: Mol Vis – volume: 9 start-page: 181 year: 2014 ident: e_1_3_3_29_1 article-title: Complement factor H Y402H and LOC387715 A69S polymorphisms in association with age-related macular degeneration in Iran publication-title: J Ophthalmic Vis Res – ident: e_1_3_3_26_1 doi: 10.1093/hmg/ddl396 – ident: e_1_3_3_14_1 doi: 10.1167/iovs.08-3240 – volume: 28 start-page: 1373 year: 2008 ident: e_1_3_3_31_1 article-title: Association of CFH, LOC387715, and HTRA1 polymorphisms with exudative age-related macular degeneration in a northern Chinese population publication-title: Mol Vis – ident: e_1_3_3_28_1 doi: 10.1001/archopht.125.1.55 – ident: e_1_3_3_30_1 doi: 10.1111/j.1755-3768.2009.01687.x – ident: e_1_3_3_15_1 doi: 10.1167/iovs.09-3928 – ident: e_1_3_3_10_1 doi: 10.1093/hmg/ddm212 – ident: e_1_3_3_35_1 doi: 10.1007/s00251-004-0660-7 – ident: e_1_3_3_11_1 doi: 10.1007/s00439-010-0805-8 – ident: e_1_3_3_22_1 doi: 10.1371/journal.pone.0003833 – ident: e_1_3_3_3_1 doi: 10.1016/j.ophtha.2010.06.040 – ident: e_1_3_3_33_1 doi: 10.3980/j..2222-3959.2012.02.02 – ident: e_1_3_3_32_1 doi: 10.1001/archophthalmol.2009.237 – ident: e_1_3_3_19_1 doi: 10.1080/13816810.2017.1393829 – ident: e_1_3_3_36_1 doi: 10.1080/13816810.2016.1237664 – ident: e_1_3_3_17_1 doi: 10.1007/s00417-013-2442-0 – ident: e_1_3_3_18_1 doi: 10.1186/s12974-016-0776-3 |
SSID | ssj0022115 |
Score | 2.2129486 |
SecondaryResourceType | review_article |
Snippet | Complement factor H (CFH) Y402 H (rs1061170) and age-related maculopathy susceptibility2 (ARMS2)/LOC387715 A69 S (rs10490924) polymorphisms shown to have... : Complement factor H (CFH) Y402 H (rs1061170) and age-related maculopathy susceptibility2 (ARMS2)/LOC387715 A69 S (rs10490924) polymorphisms shown to have... Complement factor H (CFH) Y402 H (rs1061170) and age-related maculopathy susceptibility2 (ARMS2)/LOC387715 A69 S (rs10490924) polymorphisms shown to have... |
SourceID | proquest pubmed crossref informaworld |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 301 |
SubjectTerms | age-related macular degeneration (AMD) ARMS2/LOC387715 A69S CFH Y402H Meta-analysis synergistic effect |
Title | Association of combined complement factor H Y402H and ARMS2/LOC387715 A69S polymorphisms with age-related macular degeneration: an updated meta-analysis |
URI | https://www.tandfonline.com/doi/abs/10.1080/13816810.2020.1765396 https://www.ncbi.nlm.nih.gov/pubmed/32406777 https://www.proquest.com/docview/2403032416 |
Volume | 41 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fb9MwELdKJyFeEP8Z_2Qk3qp0TZzEDm_tYKomyiS2SdtT5MTOWmltqjV9GJ-Ez8Un4i52MhcVxniJWiu-uL5fbd_l7neEfGCwZ-a-Up4SSnphoLGQe8K9WERJnEkZaV1H-X6Nx6fh4Vl01un8dKKW1lXWz79vzSv5H61CG-gVs2TvoNlWKDTAZ9AvXEHDcP0nHTtza8PDwc7VysSJ134_W0-nN-6dgwk3rl8VDL9NjpEP9cvRPhOc-1FvGCfHWK7hel7CtM9W8ybn7UJ7dbILyJxLE7Gq9EXNVN0EhcD6sF4qc4uupCcty4l76j1aTqupvMQwfOxcORH2hzLLJBb6uuqNysW1VHV0waScyvlcKixrstKzFsDnskmNn-ipmrXuoXKqZ-ivMdlHq3KtXG8GmK7oKWXOAgwnCA850sz-ZNp4GHpI9Oeu2oYuy6IzdJZgZp0j2n7jWzcKE1mJT8OH9XEofZ8jT-8WYu7fNsw2jNG3_KqNmBTFpFbMPbITgOky6JKd4ejT6KB1A4DJHdVuAPtLm7wyMdjbOp6NE9MGn-6fraL6dHTyiDy0Zg0dGow-Jh29eELuT2zgxlPyw4EqLQvaQJXeQJUaqNIxraFKAaq0hupeC1SKQKUbQKUIVOoAlVqgUheoH0EatTClGzB9Rk4PPp_sjz1bFMTLWRxXHgskC8FuSAquE11kgqmiCBPNYFEB24QrmUseI0-dkEoUGcszrsQgi5RSRQYb2HPSXZQL_ZLQIJECViOpIqZBQi60HxahYELogKtI7ZKwmfg0t4z5WLjlMv2r4ndJv-22NJQxt3VIXK2mVe2rK0xhnZTd0vd9A4EUNgZ82ycXulyvUiTaHIC55MM9Lww22uEgC2fMOX9116G-Jg9u_rVvSLe6Wuu3cCqvsncW5r8APl_YMg |
linkProvider | EBSCOhost |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+of+combined+complement+factor+H+Y402H+and+ARMS2%2FLOC387715+A69S+polymorphisms+with+age-related+macular+degeneration%3A+an+updated+meta-analysis&rft.jtitle=Ophthalmic+genetics&rft.au=Jabbarpoor+Bonyadi%2C+Mohammad+Hossein&rft.au=Yaseri%2C+Mehdi&rft.au=Soheilian%2C+Masoud&rft.date=2020-07-03&rft.issn=1381-6810&rft.eissn=1744-5094&rft.volume=41&rft.issue=4&rft.spage=301&rft.epage=307&rft_id=info:doi/10.1080%2F13816810.2020.1765396&rft.externalDBID=n%2Fa&rft.externalDocID=10_1080_13816810_2020_1765396 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1381-6810&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1381-6810&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1381-6810&client=summon |